Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Metadatos
Mostrar el registro completo del ítemAutor
Álvarez Mercado, Ana Isabel; del Valle Cano, Ana; Fernández Cabrera, Mariana Fátima; Fontana Gallego, LuisEditorial
MDPI
Materia
Androbolome Breast cancer Estrobolome Microbiome Microbiota
Fecha
2023-01-10Referencia bibliográfica
Álvarez-Mercado, A.I... [et al.]. Gut Microbiota and Breast Cancer: The Dual Role of Microbes. Cancers 2023, 15, 443. [https://doi.org/10.3390/cancers15020443]
Patrocinador
Junta de Andalucia PI-0538-2017 B-CTS-254-UGR18 B-CTS-254-UGR18 RPS 24665; Programa Operativo FEDER Andalucia 2014-2020, Junta de Andalucia, Spain RPS 24665Resumen
Breast cancer is the most frequently diagnosed cancer and also one of the leading causes of
mortality among women. The genetic and environmental factors known to date do not fully explain
the risk of developing this disease. In recent years, numerous studies have highlighted the dual
role of the gut microbiota in the preservation of host health and in the development of different
pathologies, cancer among them. Our gut microbiota is capable of producing metabolites that protect
host homeostasis but can also produce molecules with deleterious effects, which, in turn, may trigger
inflammation and carcinogenesis, and even affect immunotherapy. The purpose of this review is to
describe the mechanisms by which the gut microbiota may cause cancer in general, and breast cancer
in particular, and to compile clinical trials that address alterations or changes in the microbiota of
women with breast cancer.